The number of people with susceptibility test result for rifampicin in Kenya
Kenya: The number of people with susceptibility test result for rifampicin was 63.13 in 2021. ▲ Rising
Latest (2021)
63.13
Change on year
down 25.6%
World rank
107th
of 146 countries
All-time high
84.91
in 2020
All-time low
63.13
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Kenya, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Kenya recorded 63.13 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 25.6% on the previous year and down 1.1% over five years.
That places Kenya 107th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Kenya, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 63.83 | — |
| 2018 | 64.18 | +0.6% |
| 2019 | 76.1 | +18.6% |
| 2020 | 84.91 | +11.6% |
| 2021 | 63.13 | -25.6% |
Kenya compared with similar countries
- Kenya's 63.13 is below the median for lower middle income countries, which is 78.77, 80% of the median. (32 countries reporting)
- Kenya's 63.13 is above the median for Sub-Saharan Africa, which is 61.16, 1.0× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 68.03 | 63.83 | 76.1 | 3 |
| 2020s | 74.02 | 63.13 | 84.91 | 2 |
Countries ranked near Kenya
- 104 United Arab Emirates 69.7 compare
- 105 Cape Verde 69.01 compare
- 106 Burkina Faso 67.26 compare
- 108 Japan 62.2 compare
- 109 Croatia 60.19 compare
- 110 Trinidad and Tobago 59.38 compare
More health data for Kenya
- Un projection of annual infant deaths, annual growth rate -1.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6026 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,119 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,059 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0621 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Kenya?
- The number of people with susceptibility test result for rifampicin in Kenya was 63.13 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Kenya?
- The highest recorded value was 84.91 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Kenya?
- The lowest recorded value was 63.13 in 2021.
- How does Kenya rank for the number of people with susceptibility test result for rifampicin?
- Kenya ranks 107th out of 146 countries with data for 2021.
- Where does this Kenya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).